These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28817866)

  • 1. Genomic Medicine in Primary Care.
    Hajek C
    S D Med; 2017 Spec; Spec No():62-65. PubMed ID: 28817866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision Cardiovascular Medicine: State of Genetic Testing.
    Giudicessi JR; Kullo IJ; Ackerman MJ
    Mayo Clin Proc; 2017 Apr; 92(4):642-662. PubMed ID: 28385198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Personal Genomic Data within Primary Care: A Bioinformatics Approach to Pharmacogenomics.
    Overkleeft R; Tommel J; Evers AWM; den Dunnen JT; Roos M; Hoefmans MJ; Schrader WE; Swen JJ; Numans ME; Houwink EJF
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33266138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision Medicine, Cardiovascular Disease and Hunting Elephants.
    Joyner MJ
    Prog Cardiovasc Dis; 2016; 58(6):651-60. PubMed ID: 26902518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
    Chan SL; Jin S; Loh M; Brunham LR
    Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly personalized reports for personalized drug selection by expert systems as clinical decision support.
    Hizel HC
    Per Med; 2017 Mar; 14(2):93-97. PubMed ID: 29754552
    [No Abstract]   [Full Text] [Related]  

  • 9. Exome sequencing a review of new strategies for rare genomic disease research.
    Brown TL; Meloche TM
    Genomics; 2016 Oct; 108(3-4):109-114. PubMed ID: 27387609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
    La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
    Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
    Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
    Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating Genomic Advances to Physical Therapist Practice: A Closer Look at the Nature and Nurture of Common Diseases.
    Curtis CL; Goldberg A; Kleim JA; Wolf SL
    Phys Ther; 2016 Apr; 96(4):570-80. PubMed ID: 26637647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the development of personalized genomic medicine and surgery.
    Brunicardi FC; Gibbs RA; Wheeler DA; Nemunaitis J; Fisher W; Goss J; Chen C
    World J Surg; 2011 Aug; 35(8):1693-9. PubMed ID: 21424870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: Chasing Perfection.
    Gaedigk A
    Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized medicine: hope or hype?
    Salari K; Watkins H; Ashley EA
    Eur Heart J; 2012 Jul; 33(13):1564-70. PubMed ID: 22659199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
    Reynolds KK; Pierce DL; Weitendorf F; Linder MW
    Per Med; 2017 May; 14(3):221-233. PubMed ID: 29767587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care.
    Sadee W
    Pharm Res; 2017 Aug; 34(8):1535-1538. PubMed ID: 28493098
    [No Abstract]   [Full Text] [Related]  

  • 20. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.